HLN
Haleon plc
NYSE: HLN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$9.24
-0.65% today
Updated 2026-04-30
Market cap
$42.18B
P/E ratio
18.98
P/S ratio
3.82x
EPS (TTM)
$0.50
Dividend yield
0.74%
52W range
$9 – $11
Volume
8.4M
Haleon plc (HLN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $35.71B | $34.13B | $34.45B | $34.81B | $34.05B | $34.31B |
| Cash & equivalents | $340.00M | $334.00M | $414.00M | $684.00M | $1.04B | $2.19B |
| Current assets | $5.81B | $5.01B | $5.25B | $4.06B | $4.82B | $5.72B |
| Total liabilities | $8.30B | $7.91B | $7.97B | $18.36B | $17.33B | $18.09B |
| Current liabilities | $4.27B | $4.01B | $4.24B | $4.37B | $4.64B | $5.81B |
| Long-term debt | — | — | $0.00 | $10.00B | $8.80B | $8.54B |
| Shareholder equity | $27.32B | $26.11B | $26.36B | $16.33B | $16.61B | $16.17B |
| Retained earnings | $5.11B | $37.76B | $37.99B | $26.73B | $27.47B | $27.27B |
| Accounts receivable | $3.99B | $1.35B | $3.83B | $1.49B | $1.35B | $1.90B |
| Inventory | $1.21B | $949.00M | $951.00M | $1.35B | $1.41B | $1.19B |
| Goodwill | $8.17B | $8.27B | $8.25B | $8.40B | $8.32B | $8.20B |